These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


829 related items for PubMed ID: 12913768

  • 41. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H.
    J Infect Dis; 2008 Apr 01; 197(7):950-6. PubMed ID: 18419470
    [Abstract] [Full Text] [Related]

  • 42. Immune response to measles vaccine in 6 month old infants in Papua New Guinea.
    Kurubi J, Vince J, Ripa P, Tefuarani N, Riddell M, Duke T.
    Trop Med Int Health; 2009 Feb 01; 14(2):167-73. PubMed ID: 19171008
    [Abstract] [Full Text] [Related]

  • 43. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 44. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.
    Vaccine; 2006 Jan 30; 24(5):683-90. PubMed ID: 16154241
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT, Monteiro O, Tabard P, Cliff J.
    Bull World Health Organ; 1994 Jan 30; 72(2):227-31. PubMed ID: 8205642
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Measles antibody response in vaccinated children.
    Evliyaoğlu N, Altintaş D, Kiliç NB, Alhan SE, Onenli N, Güneşer S, Bahçebaşi T.
    Turk J Pediatr; 1996 Jan 30; 38(3):315-21. PubMed ID: 8827900
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
    Ceyhan M, Kanra G, Erdem G, Kanra B.
    Vaccine; 2001 Aug 14; 19(31):4473-8. PubMed ID: 11483273
    [Abstract] [Full Text] [Related]

  • 52. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J, Peters N, Hüttermann U, Rieger C.
    Klin Padiatr; 2006 Aug 14; 218(4):213-20. PubMed ID: 16819702
    [Abstract] [Full Text] [Related]

  • 53. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G, Boulianne N, Ratnam S, Corriveau A.
    Pediatrics; 1996 Feb 14; 97(2):232-5. PubMed ID: 8584383
    [Abstract] [Full Text] [Related]

  • 54. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
    Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM.
    J Infect Dis; 2001 Oct 01; 184(7):817-26. PubMed ID: 11528592
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 42.